Isolation and identification of a vardenafil analogue in a dietary supplement

Journal of Food and Drug Analysis

Volumn 15, Issue 3, 2007, Pages 220-227

  Lai, Kuo Chih ^a   Liu, Yi Chu ^a   Tseng, Mu Chang ^a   Lin, Yun Lian ^b   Lin, Jer Huei ^a  

^a Ministry of Health and Welfare   (Taiwan)

^b National Research Institute of Chinese Medicine   (Taiwan)

Author keywords

LC MS MS; NMR; Vardenafil analogue

Indexed keywords

2 (2 ETHOXYPHENYL) 5 METHYL 7 PROPYLIMIDAZO[5,1 F][1,2,4]TRIAZIN 4(3H) ONE; ALCOHOL; ILLICIT DRUG; PHENYL GROUP; PHOSPHODIESTERASE V INHIBITOR; UNCLASSIFIED DRUG; VARDENAFIL; VARDENAFIL DERIVATIVE;

ARTICLE; COLUMN CHROMATOGRAPHY; DIET SUPPLEMENTATION; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG MARKETING; DRUG STRUCTURE; ERECTILE DYSFUNCTION; LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS; TAIWAN; TANDEM MASS SPECTROMETRY;

EID: 36448991191     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Terrett, N. K., Bell, A. K., Brown, D. and Ellis, P. 1996. Sildenafil (Viagra) a potent and selective inhibitor of type-5 cyclic GMP phosphodiesterase with utility for the treatment of male erectile dysfunction. Bioorg. Med. Chem. Lett. 6: 1819-1824.
2. Boolell, M., Allen, M. J., Ballard, S. A., Gepi-Attee, S., Muirhead, G. J., Naylor, A. M., Osterloh, I. H. and Gingell, C. 1996. Sildenafil: an orally active type-5 cyclic GMP specific phosphodiesterase inhibitor for treatment of penile erectile dysfunction. Int. J. Impotence Res. 8: 47-52.
3. Beavo, J. A. 1995. Cyclic nucleotide phosphodiesterases functional implication of multiple isoforms. Physiol. Rev. 75: 725-748.
4. Takako, M., Sutemi, S., Kiyoko, K., Fusako, I., Jyunichi, N., Hisashi, K. and Ichiro, Y. 2001. Identification system for sildenafil in health foods. Yakugaku Zasshi 121: 765-769.
5. Shin, M. H., Hong, M. K., Kim, W. S., Lee, Y. J. and Jeoung, Y. C. 2003. Identification of a new analogue of sildenafil added illegally to a functional food marketed for penile erectile dysfunction. Food Addit. Contam. 20: 793-796.
6. Blok-Tip, L., Zomer, B., Bakker, F., Hartog, K. D., Hamzink, M., ten Hove, J., Vredenbregt, M. and de Kaste, D. 2004. Structure elucidation of sildenafil analogues in herbal products. Food Addit. Contam. 21: 737-748.
7. Reepmeyer, J. C. and Woodruff, J. T. 2006. Use of liquid chromatography-mass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a "natural" herbal dietary supplement. J. Chromatogr. A 1125: 67-75.
8. Tseng, M. C. and Lin, J. H. 2002. Determination of sildenafil citrate adulterated in a dietary supplement capsule by LC/MS/MS. J. Food Drug Anal. 10: 112-119.
9. Lai, K. C., Liu, Y. C., Tseng, M. C. and Lin, J. H. 2006. Isolation and identification of a sildenafil analogue illegally added in dietary supplements. J. Food Drug Anal. 14: 19-23.
10. Lin, M. C., Liu, Y. C. and Lin, J. H. 2006. Identification of a sildenafil analogue adulterated in two herbal food supplements. J. Food Drug Anal. 14: 260-264.